EP vs REGN · rev $34.2M vs P/E 14, rev $14.34B
Empire Petroleum Corp (EP) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Empire Petroleum Corp (EP) is a oil & gas e&p company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported EP revenue for 2025-12-31 was $34.2M. Net income was -$72.1M. Revenue was down 21.6% from 2024-12-31 to 2025-12-31. EP currently screens at market cap $186.8M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
EP currently screens at market cap $186.8M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the EP and REGN stock pages for the full models.
Not investment advice.